Estados financieros detallados de Silence Therapeutics plc (SLN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Silence Therapeutics plc registró ingresos de $559000 en el último ejercicio fiscal, con un CAGR de 5 años del -36.7%.
Márgenes de los últimos 12 meses: margen bruto 51.0%, margen operativo -108.8%, margen neto -97.6%.
Al precio actual de $12.50, SLN presenta beneficios negativos (P/E no significativo) y un ROE del -106.94%. La capitalización bursátil es de $590M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $770000 | $16000 | 0 | $244000 | $5.5M | $12.4M | $17.7M | $25.4M | $43.3M | $559000 |
| Coste de Ventas | $8.7M | $7.9M | $9.7M | 0 | $3.8M | $7.5M | $11.0M | $10.3M | $11.8M | $215000 |
| Beneficio Bruto | -$7.9M | -$7.9M | -$9.7M | $244000 | $1.7M | $5.0M | $6.7M | $15.1M | $31.4M | $344000 |
| I+D | $8.7M | $7.9M | $9.7M | $13.3M | $20.2M | $30.8M | $35.5M | $44.0M | $67.9M | $67.8M |
| Generales y Administrativos | $4.0M | $6.5M | $10.8M | $9.6M | $14.0M | $20.0M | $20.9M | $20.6M | $26.9M | $22.3M |
| Gastos Operativos | $4.0M | $6.5M | $10.8M | $23.0M | $37.6M | $50.8M | $56.4M | $64.7M | $94.8M | $90.1M |
| Beneficio Operativo | -$11.9M | -$14.4M | -$20.6M | -$22.7M | -$35.8M | -$45.8M | -$49.8M | -$49.6M | -$63.3M | -$89.8M |
| EBITDA | -$11.6M | -$3.3M | -$20.2M | -$22.4M | -$35.5M | -$45.4M | -$39.9M | -$49.8M | -$49.0M | -$88.0M |
| Gastos por Intereses | 0 | $15000 | 0 | $33000 | $16000 | $8000 | $47000 | $34000 | 0 | 0 |
| Beneficio Antes de Impuestos | -$10.4M | -$3.8M | -$20.5M | -$22.9M | -$36.0M | -$45.9M | -$40.5M | -$50.3M | -$44.5M | -$88.6M |
| Impuestos | -$1.9M | -$2.2M | -$2.1M | -$3.3M | -$3.5M | -$6.4M | $560854 | -$7.0M | $845000 | $11000 |
| Beneficio Neto | -$8.4M | -$1.6M | -$18.4M | -$19.6M | -$32.5M | -$39.4M | -$41.0M | -$43.3M | -$45.3M | -$88.6M |
| BPA | $-0.36 | $-0.07 | $-0.78 | $-0.78 | $-1.11 | $-1.35 | $-3.78 | $-3.48 | $-2.37 | $-5.67 |
| BPA Diluido | $-0.36 | $-0.07 | $-0.78 | $-0.78 | $-1.11 | $-1.35 | $-3.78 | $-3.48 | $-2.37 | $-5.67 |
| Acciones en Circulación (Diluidas) | $23.3M | $23.3M | $23.4M | $25.0M | $27.3M | $29.7M | $10.7M | $12.4M | $15.4M | $15.7M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $39.0M | $42.7M | $21.5M | $13.5M | $27.4M | $73.5M | $54.8M | $54.4M | $96.9M | $11.3M |
| Inversiones a Corto | 0 | $319000 | $5.0M | $20.0M | $10.0M | 0 | $16.3M | 0 | $20.8M | $73.8M |
| Cuentas por Cobrar | $810000 | $2.0M | $2.4M | $4000 | $29.3M | $331000 | $915000 | $19.0M | $776375 | $24.6M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $42.0M | $45.5M | $29.5M | $37.5M | $76.4M | $86.3M | $96.7M | $81.6M | $149.7M | $118.7M |
| Inmovilizado Material | $1.4M | $1.2M | $921000 | $611000 | $1.1M | $1.9M | $2.2M | $2.3M | $1.6M | $1.7M |
| Fondo de Comercio | $7.7M | $8.0M | $8.1M | $7.7M | $8.1M | $7.6M | $8.0M | $10.0M | $7.5M | $10.6M |
| Activos Intangibles | $45000 | $28000 | $64000 | $34000 | $17000 | $24000 | $320000 | $362000 | $249206 | $288000 |
| Activos Totales | $55.8M | $55.0M | $38.9M | $46.1M | $86.0M | $96.2M | $107.5M | $94.5M | $161.9M | $131.4M |
| Cuentas por Pagar | $528000 | $462000 | $1.1M | $1.8M | $2.3M | $4.1M | $3.2M | $2.6M | $3.0M | $4.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.6M | $2.7M | $3.8M | $9.7M | $25.6M | $15.2M | $21.9M | $17.7M | $13.4M | $13.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.6M | $2.7M | $3.8M | $25.2M | $76.9M | $87.7M | $85.4M | $77.1M | $54.8M | $69.1M |
| Reservas | -$116.0M | -$116.4M | -$133.8M | -$152.0M | -$184.2M | -$223.0M | -$263.3M | -$431.9M | -$378.6M | -$562.6M |
| Patrimonio Neto | $54.2M | $52.4M | $35.1M | $20.9M | $9.1M | $8.5M | $22.1M | $22.0M | $107.0M | $62.3M |
| Deuda Total | 0 | 0 | 0 | $287000 | $341000 | $137000 | $446000 | $273808 | $93452 | $160000 |
| Deuda Neta | -$39.0M | -$43.1M | -$26.5M | -$33.2M | -$37.1M | -$73.4M | -$70.7M | -$54.2M | -$117.6M | -$85.0M |
| Capital Circulante | $40.4M | $42.9M | $25.7M | $27.8M | $50.8M | $71.2M | $74.7M | $64.0M | $136.2M | $105.0M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$10.4M | -$3.8M | -$20.5M | -$22.9M | -$36.0M | -$61.9M | -$50.3M | -$50.3M | -$28.9M | -$88.6M |
| Amortizaciones | $310000 | $433000 | $399000 | $482000 | $496000 | $576294 | $596000 | $498000 | $473860 | $555000 |
| Compensación en Acciones | $475000 | $638000 | $681000 | $584000 | $4.4M | $11.7M | $12.7M | $13.1M | $10.4M | $8.1M |
| Cambio en Capital Circulante | -$1.0M | $664000 | -$233000 | $21.1M | $18.7M | $52.4M | -$19.4M | -$11.7M | -$26.4M | $10.2M |
| Flujo de Caja Operativo | -$10.1M | -$9.6M | -$16.8M | $1.7M | -$10.8M | $9.2M | -$57.0M | -$39.4M | -$54.1M | -$62.3M |
| Inversiones (CapEx) | -$537000 | -$173000 | -$188000 | -$9000 | -$514000 | -$1.8M | -$545000 | -$45000 | -$168607 | -$55000 |
| Adquisiciones | 0 | -$13.2M | -$58000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$101000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$10.6M | -$9.8M | -$16.9M | $1.7M | -$11.3M | $7.4M | -$57.6M | -$39.4M | -$54.2M | -$62.3M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -97.9% | -100.0% | +2145.5% | +126.6% | +42.2% | +43.7% | +70.5% | -98.7% | ||
| Crecimiento Beneficio Neto (anual) | +80.8% | -1037.9% | -6.4% | -66.2% | -21.1% | -4.1% | -5.4% | -4.7% | -95.6% | |
| Crecimiento BPA (anual) | +80.7% | -1025.5% | +0.0% | -42.3% | -21.6% | -180.0% | +7.9% | +31.9% | -139.2% | |
| Cambio en Acciones (anual) | +0.2% | +0.5% | +6.8% | +8.8% | +8.8% | -63.8% | +15.2% | +24.7% | +2.1% | |
| Crecimiento FCF (anual) | +7.8% | -73.4% | +110.1% | -757.2% | +165.4% | -879.8% | +31.6% | -37.6% | -15.0% | |
| Margen Bruto | -1031.3% | -49543.8% | 100.0% | 31.3% | 39.9% | 37.8% | 59.3% | 72.7% | 61.5% | |
| Margen Operativo | -1546.2% | -89943.8% | -9317.2% | -654.3% | -369.0% | -281.9% | -195.5% | -146.4% | -16056.0% | |
| Margen EBITDA | -1506.0% | -20793.8% | -9161.9% | -648.5% | -365.9% | -226.2% | -196.2% | -113.2% | -15750.6% | |
| Margen Neto | -1096.1% | -10112.5% | -8025.4% | -594.0% | -317.4% | -232.4% | -170.5% | -104.7% | -15851.9% | |
| Margen FCF | -1377.0% | -61075.0% | 704.1% | -206.1% | 59.5% | -326.2% | -155.3% | -125.3% | -11149.6% | |
| Tasa Impositiva Efectiva | 18.5% | 57.1% | 10.3% | 14.4% | 9.7% | 14.1% | -1.4% | 14.0% | -1.9% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.46 | $-0.42 | $-0.72 | $0.07 | $-0.41 | $0.25 | $-5.37 | $-3.19 | $-3.52 | $-3.96 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $23.3M | $23.3M | $23.4M | $25.0M | $27.3M | $29.7M | $10.7M | $12.4M | $15.4M | $15.7M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -106.94% |
| Rentabilidad sobre capital invertido | -71.25% |
| Rentabilidad sobre activos | -56.34% |
| Margen bruto | 51.00% |
| Margen operativo | -10880.25% |
| Margen neto | -9759.23% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.42 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -43.88 | -208.28 | -19.60 | -18.85 | -14.51 | -13.07 | -3.34 | -3.92 | -2.32 | -1.07 |
| P/VC | 6.78 | 6.43 | 10.22 | 17.61 | 48.45 | 61.38 | 6.13 | 7.68 | 0.79 | 1.54 |
| P/V | 477.31 | 21031.88 | 0.00 | 1509.12 | 80.11 | 42.15 | 7.66 | 6.65 | 1.96 | 171.24 |
| Margen Bruto | -1031.3% | -49543.8% | 0.0% | 100.0% | 31.3% | 39.9% | 37.8% | 59.3% | 72.7% | 61.5% |
| Margen Operativo | -1546.2% | -89943.8% | 0.0% | -9317.2% | -654.3% | -369.0% | -281.9% | -195.5% | -146.4% | -16056.0% |
| Margen Neto | -1096.1% | -10112.5% | 0.0% | -8025.4% | -594.0% | -317.4% | -232.4% | -170.5% | -104.7% | -15851.9% |
Empresas relacionadas: ACIU · ALDX · AMRN · ANRO · CAPR · CTNM · KYTX
Explorar sector: Healthcare · Biotechnology
Más secciones de SLN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones